Rising rates of cancer in the Middle East and North Africa have led the World Health Organization (WHO) to recommend that countries in the region develop sustainable cancer control strategies to address malignancies that most affect their populations [1]. In Morocco, breast cancer is the most commonly...
RNA post-transcriptional modifications are increasingly being studied in recent years [1, 2]. These modifications, which exceed 100 in number, include pseudouridine, N6-methyladenosine (m6A) [3], N1-methyladenosine (m1A) [4], and 5-methylcytosine (m5C) [5]. The important role of m6A modification for...
Breast cancer ranks as one of the most prevalent malignant tumors globally. According to the Global Cancer Burden 2020 data, it accounts for about 11.7% of all new cancer cases worldwide, ranking first in the global cancer incidence rate [1]. In China alone, there are about 416,000 new cases of breast...
Breast cancer poses the foremost threat to women’s health, exhibiting the highest incidence among female cancers and the second-highest mortality rate [1]. As the exploration of breast cancer treatment modalities progresses, neoadjuvant chemotherapy (NACT) has emerged as a standard clinical intervention,...
Breast cancer is the most prevalent malignancy in women and poses a substantial global health burden. Approximately 2.3 million new cases have been reported, with an estimated 685,000 deaths attributed to this disease in 2020 [1]. Currently, treatment alternatives for breast cancer, especially metastatic...